Expanded Clinical Study of the Tendyne Mitral Valve System
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 191 participants.
Also called NCT02321514
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 191 participants
- Sponsor
- Registry
-
NCT02321514
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Australia, France, Germany, Italy, Netherlands, Norway, Sweden, Switzerland, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02321514. Allocation not applicable; no masking; primary purpose treatment. Start 2014-11 (actual); primary completion 2020-07 (actual). Results posted on 2021-09-02.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Expanded Clinical Study of the Tendyne Mitral Valve System
- Condition
- Mitral Valve Regurgitation
- Intervention (Device)
- Tendyne Mitral Valve System
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct02321514- Content hash
287b5105d95ed426b77e7a00d6ae394d196954505d68f8d667f17d0bde0b0c93